Patent details

LUC00147 Product Name: giltéritinib ou un sel de celui-ci

Basic Information

Publication number:
LUC00147
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP107721771
Legal Status:
Inactive
Application number:
LUC00147
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/19/1399
Marketing Authorization Type:
Marketing Authorization Date:
28/10/2019
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
06/02/2020
First Marketing Authorization date:
28/10/2019
Grant date:
12/02/2021
Activation date:
Publication date:
10/02/2020
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
28/10/2034
SPC Extension Expiration:
28/10/2034
Rejection date:
Withdrawal date:

Owner

From:
06/02/2020
 
 

Name:
Astellas Pharma Inc.
Address:
5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411, Japan (JP)

Name:
Kotobuki Pharmaceutical Co. Ltd.
Address:
6351, Oaza Sakaki Sakaki-machi, Hanishina-gun, Nagano 389-0697, Japan (JP)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
06/02/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2020/04
Publication date:
09/03/2020
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2021/04
Publication date:
08/03/2021
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
31/05/2030
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
06/02/2020 General Document 12
06/02/2020 General Document 34
12/02/2021 Outgoing Correspondence 1
12/02/2021 Publication 1
06/02/2020 General Document 3
12/02/2021 Certificate 1
06/02/2020 Application Form 4
10/02/2020 Outgoing Correspondence 1
10/02/2020 Publication 1